TRS120 Antibody

What is TRS120 and what cellular functions does it regulate?

TRS120 functions as a specific subunit of the TRAPPII complex, which plays crucial roles in membrane trafficking pathways. It is particularly important for traffic from the early endosome to the late Golgi apparatus . Studies have demonstrated that TRS120 is not essential for the exocytic pathway but is required for proper trafficking of certain proteins that recycle through the early endosome .

In plants, the TRS120 protein contains plant-specific regions that harbor phosphorylation sites, suggesting evolutionary specialization . These phosphorylation sites reside in unstructured, flexible, and accessible regions of the protein, consistent with common patterns observed in modified amino acid residues . Structurally, cross-kingdom alignment with yeast TRAPPII shows that some phosphorylation sites face the active site chamber or Rab GTPase binding pocket, indicating potential regulatory functions .

What are the key characteristics of commercial TRS120 antibodies?

Commercial TRS120 antibodies, such as those available from suppliers like Cusabio, are typically generated in rabbits as polyclonal antibodies and purified using Protein A/G affinity chromatography . These antibodies are generally supplied in unconjugated form and may be accompanied by positive control recombinant immunogen protein/peptide and pre-immune serum for validation purposes .

The specificity of these antibodies is generally directed toward yeast TRS120 protein, with immunogens often derived from recombinant Schizosaccharomyces pombe (fission yeast) TRS120 protein . The commercial preparations are stored at -20°C or -80°C and shipped on blue ice to maintain antibody integrity .

What experimental applications are suitable for TRS120 antibodies?

TRS120 antibodies are primarily utilized in applications such as ELISA and Western blotting for detection and quantification of TRS120 protein . These antibodies can be employed in immunoprecipitation studies to investigate protein-protein interactions, as demonstrated in research identifying the dynamic interactome of TRAPPII complex components .

For cellular localization studies, TRS120 antibodies can be used in immunofluorescence microscopy to visualize the distribution of TRS120 protein within cellular compartments. This approach has been valuable in studies examining the co-localization of TRS120 with markers of the early endosome and Golgi apparatus .

In mutant studies, TRS120 antibodies have been instrumental in confirming the absence or alteration of TRS120 protein expression, helping researchers correlate phenotypic changes with protein levels .

How does phosphorylation regulate TRS120 function in the TRAPPII complex?

TRS120 contains multiple phosphorylation sites that appear to regulate its function within the TRAPPII complex. Mass spectrometry analysis of TRS120 co-immunoprecipitates has revealed in vivo evidence for phosphorylation at specific sites by shaggy-like kinases (AtSKs) . Three GSK3 sites found to be phosphorylated in vivo have been designated as α (TRS120-S922:S923), β (TRS120-S971:S973:S974:S975), and γ (TRS120-S1165) .

These phosphorylation sites are strategically positioned in plant-specific moieties of TRS120-T2 at the dimer interface, suggesting a role in regulating protein-protein interactions within the complex . Structural predictions using AlphaFold indicate that these sites reside in unstructured, flexible regions of the protein, making them accessible for modification by kinases .

The functional significance of these phosphorylation events is evident from studies using phosphomimetic mutations. When all three sites were mutated to aspartate to mimic constitutive phosphorylation (TRS120-T2 SαβγD), the interaction between TRS120 and BIN2 (a shaggy-like kinase) was almost abolished, while TRAPPII complex interactions remained intact . This suggests phosphorylation may regulate the kinase-substrate interaction through a "kiss-and-run" mechanism, consistent with the observation that BIN2 interacts more strongly with unphosphorylated than phosphorylated substrates .

What methodologies can be used to investigate TRS120 phosphorylation states?

Researchers investigating TRS120 phosphorylation states can employ multiple complementary approaches:

• Mass Spectrometry Analysis: IP-MS (immunoprecipitation followed by mass spectrometry) has proven effective in detecting phosphopeptides in TRS120 co-immunoprecipitates, providing evidence for in vivo phosphorylation at specific sites . This technique allows for identification of specific phosphorylated residues and quantification of phosphorylation levels.

• Site-Directed Mutagenesis: Generating phosphorylation site variants by mutating serine/threonine residues to non-phosphorylatable alanine (A) or phosphomimetic aspartate (D) enables functional studies of phosphorylation . For example, mutations in the TRS120-Sβ site can be designated as TRS120-SβA or TRS120-SβD to study the effects of phosphorylation state on protein function .

• In Vitro Kinase Assays: These assays can determine whether TRS120 is a direct substrate of specific kinases and identify which sites are preferentially phosphorylated . Studies have shown that AtTRS120 is a substrate of AtSKs in clades I-III but not clade IV, with a marked preference for the TRS120-γ (S1165) site .

• Pharmacological Inhibition: Treatment with kinase inhibitors (e.g., bikinin for AtSK inhibition) or pathway modulators (e.g., PPZ for BR biosynthesis inhibition) followed by IP-MS can reveal changes in phosphorylation levels, confirming in vivo regulation . These approaches have demonstrated reduced phosphorylation of the TRS120-Sγ peptide with bikinin treatment and increased phosphorylation with PPZ treatment .

What are the effects of TRS120 mutations on membrane trafficking pathways?

Mutations in TRS120 lead to distinct membrane trafficking defects compared to mutations in other TRAPPII complex components. While mutants in the related TRAPPII component TRS130 disrupt multiple steps in the Golgi and block secretion, TRS120 mutants show more specific trafficking defects .

Most TRS120 mutants do not significantly impair general secretion, as demonstrated by pulse-chase experiments showing normal secretion of proteins into the medium . Even mutants with partial secretion defects (trs120-2 and trs120-8) showed only mild accumulation of both partially and fully glycosylated forms of invertase .

The most prominent phenotype of TRS120 mutants involves the disruption of traffic from the early endosome to the late Golgi. This is evidenced by:

• Accumulation of aberrant membrane structures resembling Berkeley bodies

• Mislocalization of recycling proteins such as GFP-Snc1p, which accumulates in enlarged structures identified as early endosomes through FM4-64 co-labeling

• Defects in targeting of Chs3p to the bud neck, indicating impaired recycling from early endosomes

These findings suggest that TRS120 plays a specialized role in endosome-to-Golgi trafficking rather than in the general secretory pathway .

How can TRS120 antibodies be used to study TRAPPII complex interactions with signaling pathways?

TRS120 antibodies are valuable tools for investigating the interactions between the TRAPPII complex and various signaling pathways, particularly brassinosteroid (BR) signaling components. Immunoprecipitation coupled with mass spectrometry (IP-MS) using TRAPPII-specific subunit antibodies has revealed significant enrichment of BR signaling components in the TRAPPII interactome .

To effectively study these interactions, researchers can:

• Conduct co-immunoprecipitation experiments using TRS120 antibodies under different environmental conditions (e.g., light vs. dark) to identify dynamic interactors . This approach has successfully detected interactions with TOR kinase and shaggy-like kinases (AtSKs) .

• Perform yeast two-hybrid (Y2H) assays to probe binary interactions between TRAPPII subunits and signaling components . Large-scale Y2H screens have identified specific interactions between TRS120 truncations and signaling proteins .

• Use comparative interactome analysis to quantify the enrichment of specific signaling pathways. Statistical analysis of TRAPPII interactors has shown significant enrichment of BR signaling components (P = 0.016) and TOR signaling .

• Validate interactions through in vitro binding assays using purified components. This can determine whether interactions are direct or mediated by other proteins .

• Apply pharmacological treatments that modulate signaling pathways (e.g., BR biosynthesis inhibitors) followed by co-immunoprecipitation to assess how pathway activation/inhibition affects TRAPPII complex interactions .

What strategies can be employed for studying TRS120 function across different species?

Studying TRS120 function across species requires careful consideration of evolutionary conservation and species-specific adaptations. Several approaches can be implemented:

• Cross-species complementation studies: Express TRS120 from different species in trs120 mutants to determine functional conservation . This approach can reveal which domains are essential for function across species.

• Structural alignment analysis: Use tools like AlphaFold and cryo-EM-generated structures to compare TRS120 proteins across kingdoms . Cross-kingdom structural alignment of plant AtTRS120 with yeast TRAPPII has revealed conserved functional domains despite sequence divergence .

• Domain-specific antibodies: Develop antibodies targeting conserved regions of TRS120 that can recognize the protein across multiple species . These can be valuable for comparative studies.

• Species-specific mutations: Generate equivalent mutations in TRS120 orthologs from different species to determine if phenotypes are conserved . The transposon mutagenesis approach used to generate yeast trs120 mutants can be adapted for other organisms .

• Heterologous expression systems: Express tagged versions of TRS120 from different species in a common host to compare localization, interactions, and post-translational modifications . This approach minimizes variability due to host-specific factors.

What controls should be included when working with TRS120 antibodies?

When working with TRS120 antibodies, several essential controls should be incorporated to ensure experimental validity:

• Pre-immune serum control: Use pre-immune serum from the same animal to establish baseline signals and identify non-specific binding . Commercial antibody preparations often include pre-immune serum specifically for this purpose.

• Positive control samples: Include recombinant TRS120 protein or cells overexpressing TRS120 to confirm antibody specificity and establish detection limits . The recombinant immunogen protein included with commercial antibodies serves as an ideal positive control.

• Negative control samples: Use samples from TRS120 knockout or knockdown models to confirm specificity . When working with yeast, trs120 mutant strains provide excellent negative controls.

• Cross-reactivity testing: Validate antibody specificity against related proteins, particularly other TRAPPII complex components, to ensure selective detection of TRS120 .

• Multiple detection methods: Confirm results using alternative techniques (e.g., mass spectrometry) to validate antibody-based findings .

How should experimental conditions be optimized for TRS120 antibody applications?

Optimizing experimental conditions for TRS120 antibody applications requires systematic testing of several parameters:

For Western blotting:

• Test different protein extraction methods to maintain TRS120 integrity

• Optimize antibody dilution (typically starting with 1:1000)

• Evaluate blocking agents to minimize background

• Test various detection systems for optimal signal-to-noise ratio

For immunoprecipitation:

• Compare different lysis buffers to maintain protein interactions

• Optimize antibody-to-protein ratios

• Consider crosslinking approaches to capture transient interactions

• Include protease and phosphatase inhibitors to preserve post-translational modifications

For immunofluorescence:

• Test different fixation methods (paraformaldehyde vs. methanol)

• Optimize permeabilization conditions

• Determine optimal antibody concentration and incubation time

• Include co-staining with subcellular markers to confirm localization

What techniques can be used to validate TRS120 antibody specificity?

Validating TRS120 antibody specificity is crucial for reliable experimental results. Several complementary approaches should be employed:

• Western blot analysis using recombinant TRS120 protein and cell lysates from various species to confirm the antibody detects a band of the expected molecular weight .

• Immunoprecipitation followed by mass spectrometry to confirm the identity of the immunoprecipitated protein as TRS120 .

• Peptide competition assays where pre-incubation of the antibody with the immunizing peptide should abolish specific binding in subsequent applications.

• Genetic approaches using TRS120 knockout/knockdown models to confirm disappearance or reduction of the specific signal .

• Epitope mapping to identify the specific region of TRS120 recognized by the antibody, which can help predict potential cross-reactivity.

• Comparison of multiple antibodies targeting different epitopes of TRS120 to confirm consistent results.

How can researchers address inconsistent results with TRS120 antibodies?

Inconsistent results with TRS120 antibodies may stem from various factors. A systematic troubleshooting approach includes:

• Antibody quality assessment: Verify antibody integrity through dot blots with the immunizing peptide. Commercial antibodies come with positive control recombinant immunogen that can be used for this purpose .

• Sample preparation optimization: Ensure proper sample handling to preserve protein integrity. For TRS120, which forms part of a complex, gentle lysis conditions may be necessary to maintain native conformation .

• Protocol standardization: Develop and strictly adhere to standardized protocols for each application. Small variations in experimental conditions can significantly impact results, especially for co-immunoprecipitation experiments studying transient interactions like those between TRS120 and shaggy-like kinases .

• Lot-to-lot variation analysis: When using commercial antibodies, test new lots against previous ones to identify potential variations. Document lot numbers and maintain reference samples .

• Cell/tissue-specific optimization: Adjust protocols based on the specific cell type or tissue being studied, as protein expression and complex formation may vary across different biological contexts .

How should researchers interpret TRS120 localization data in the context of trafficking pathways?

Interpreting TRS120 localization data requires careful consideration of the dynamic nature of membrane trafficking pathways:

• Co-localization studies: Always include established markers for specific organelles (e.g., early endosome, late Golgi) to accurately determine TRS120 localization . Studies have shown that GFP-Snc1p structures in trs120 mutants co-localize with the early endosome marker FM4-64 at early time points .

• Temporal dynamics: Consider time-course experiments to capture the dynamic nature of TRS120 localization. In trafficking studies, the distribution of markers can change significantly over time, as demonstrated by the movement of FM4-64 from early endosomes to the vacuolar membrane .

• Mutant phenotype analysis: Compare localization patterns in wild-type and mutant cells to identify trafficking defects . In trs120 mutants, the accumulation of enlarged GFP-Snc1p-containing structures indicates specific trafficking defects .

• Multiple marker analysis: Use multiple cargo proteins that follow different trafficking routes to comprehensively map TRS120 function . Studies have used both Snc1p (which recycles through the early endosome) and Chs3p to characterize trs120 mutant phenotypes .

• Quantitative assessment: Develop quantitative metrics for localization (e.g., colocalization coefficients, structure size measurements) rather than relying solely on qualitative observations .

What considerations are important when studying phosphorylation-dependent functions of TRS120?

When investigating phosphorylation-dependent functions of TRS120, researchers should consider several important factors:

• Site-specific effects: Different phosphorylation sites on TRS120 (α, β, and γ) may have distinct functional consequences . In vitro kinase assays have shown that AtSKs have a marked preference for the TRS120-γ (S1165) site .

• Kinase specificity: Multiple kinases may target the same sites with different efficiencies or under different conditions . Studies have shown that TRS120 is a substrate of AtSKs in clades I-III but not clade IV .

• Phosphorylation dynamics: Phosphorylation states can change rapidly in response to stimuli, requiring time-course experiments and appropriate experimental designs to capture these dynamics .

• Stoichiometry considerations: Partial phosphorylation may have different functional outcomes compared to complete phosphorylation of all sites . Phosphomimetic mutations (S to D) at all three sites almost abolished BIN2-TRS120 interaction, while TRAPPII complex interactions remained intact .

• Combinatorial effects: The combination of phosphorylated sites may be more important than individual site modifications . Researchers should consider creating single, double, and triple phosphorylation site mutants to dissect these effects.

• Physiological relevance: Validate in vitro findings with in vivo approaches, such as using pharmacological treatments that affect kinase activity (e.g., bikinin, PPZ) followed by phosphorylation analysis .